ClinicalTrials.Veeva

Menu

Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa

A

Ain Shams University

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Placenta Previa

Treatments

Drug: Tranexamic acid tablets
Drug: Placebo oral tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT04055194
AntenatalTRX-PP

Details and patient eligibility

About

200 pregnant women with symptomatic placenta previa with previous bleeding attacks attending Ain Shams University maternity hospital will be recruited and randomized to receive either tranexamic acid tablets (500mg four times daily) or placebo. Amount of bleeding during antepartum bleeding attacks will be estimated (by hemoglobin change from baseline at admission till delivery).

Enrollment

200 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age 28 weeks of gestation.
  • Definite and reliable diagnosis of placenta previa (defined as presence of a placenta within 2 cm of the internal os), using transvaginal ultrasound scan.
  • Haemodynamically stable pregnant women.
  • Maternal age:20-40years old.
  • Pregnant women with placenta previa, and had previous bleeding attacks or admitted with antepartum haemorrhage.

Exclusion criteria

  • Multiple pregnancy.
  • Women with bleeding tendency due to any medical disorder (ITP, thrombocytopenia, coagulopathies),or on anticoagulants .
  • Severe antepartum hemorrhage and/or hemodynamic instability that necessitates urgent intervention and delivery.
  • Women have hypersensitivity or any contraindication to use of tranexamic acid.
  • Pregnant women with placenta previa with doppler showing morbidly adherent placenta.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups, including a placebo group

Tranexamic acid group
Active Comparator group
Description:
100 pregnant women with symptomatic placenta previa with previous bleeding attacks will receive tranexamic acid tablets (500mg four times daily) till delivery.
Treatment:
Drug: Tranexamic acid tablets
Placebo group
Placebo Comparator group
Description:
100 pregnant women with symptomatic placenta previa with previous bleeding attacks will receive placebo tablets four times daily till delivery.
Treatment:
Drug: Placebo oral tablet

Trial contacts and locations

1

Loading...

Central trial contact

Amal Ramadan, MBBCh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems